SNX29-TNFRSF17 Fusion FISH Probe
The SNX29-TNFRSF17 Fusion FISH Probe is used to confirm a fusion of the SNX29 and TNFRSF17 genes. The fusion of the SNX29 and TNFRSF17 genes has been associated with Lung Adenocarcinoma, and Liver Hepatocellular Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| SNX29-TNFRSF17-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| SNX29-TNFRSF17-20-RERE | 20 (40 μL) | 200 μL |
|
|
| SNX29-TNFRSF17-20-REOR | 20 (40 μL) | 200 μL |
|
|
| SNX29-TNFRSF17-20-REGO | 20 (40 μL) | 200 μL |
|
|
| SNX29-TNFRSF17-20-REGR | 20 (40 μL) | 200 μL |
|
|
| SNX29-TNFRSF17-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| SNX29-TNFRSF17-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| SNX29-TNFRSF17-20-OROR | 20 (40 μL) | 200 μL |
|
|
| SNX29-TNFRSF17-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| SNX29-TNFRSF17-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| SNX29-TNFRSF17-20-GORE | 20 (40 μL) | 200 μL |
|
|
| SNX29-TNFRSF17-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| SNX29-TNFRSF17-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| SNX29-TNFRSF17-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| SNX29-TNFRSF17-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| SNX29-TNFRSF17-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| SNX29-TNFRSF17-20-GROR | 20 (40 μL) | 200 μL |
|
|
| SNX29-TNFRSF17-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| SNX29-TNFRSF17-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| SNX29-TNFRSF17-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| SNX29-TNFRSF17-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| SNX29-TNFRSF17-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| SNX29-TNFRSF17-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| SNX29-TNFRSF17-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| SNX29-TNFRSF17-20-AQAQ | 20 (40 μL) | 200 μL |
|
TNFRSF17 Gene Summary
The protein encoded by this gene is a member of the TNF-receptor superfamily. This receptor is preferentially expressed in mature B lymphocytes, and may be important for B cell development and autoimmune response. This receptor has been shown to specifically bind to the tumor necrosis factor (ligand) superfamily, member 13b (TNFSF13B/TALL-1/BAFF), and to lead to NF-kappaB and MAPK8/JNK activation. This receptor also binds to various TRAF family members, and thus may transduce signals for cell survival and proliferation. [provided by RefSeq, Jul 2008]
Gene Name: TNF Receptor Superfamily Member 17
Chromosome: CHR16: 12058963 -12061925
Locus: 16p13.13
SNX29 Gene Summary
The Sorting Nexin 29 (SNX29) gene is located on chr16 :12070601-12668146 at 16p13.13-p13.12.
Gene Name: Sorting Nexin 29
Chromosome: CHR16: 12070601 -12668146
Locus: 16p13.13-p13.12
Gene Diseases
The SNX29 TNFRSF17 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Lung Adenocarcinoma |
| Liver Hepatocellular Carcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|